Departments of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine and the Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, 1010 Northern Blvd, Suite #311, Great Neck, NY 11021, USA.
Department of Psychiatry, Columbia University Medical Center and the New York State Psychiatric Institute, New York, NY, USA.
Psychiatry Res. 2017 Nov;257:372-374. doi: 10.1016/j.psychres.2017.07.070. Epub 2017 Aug 1.
Marijuana use is associated with psychosis, but its effects are understudied in individuals with preexisting risk for psychotic disorders. This preliminary study examined the acute psychological and physiological effects of smoked marijuana (0.0% or 5.5% Δ-THC) in marijuana users at clinical high-risk (CHR; n = 6) to develop a psychotic disorder, and those not at risk (n = 6), under controlled laboratory conditions. CHR marijuana users exhibited temporary increases in psychotic-like states and decreases in neurocognitive performance during marijuana intoxication but control marijuana smokers did not. These findings, if replicated, may support a psychotogenic role for marijuana in CHR individuals.
大麻的使用与精神病有关,但在有精神病发病风险的个体中,其影响尚未得到充分研究。本初步研究在临床高风险(CHR;n=6)发展为精神病的大麻使用者和无风险(n=6)大麻使用者中,检查了吸食大麻(0.0%或 5.5%Δ-THC)的急性心理和生理影响,在受控实验室条件下。CHR 大麻使用者在大麻中毒期间表现出类精神病状态的暂时增加和神经认知功能的下降,但对照组大麻吸烟者没有。如果这些发现得到复制,可能支持大麻在 CHR 个体中具有致精神病作用。